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ABSTRACT 
In present scenario more than 70% of the drugs that are taken by oral route are found to be less effective as desired, to overcome this 
constraint Transdermal drug delivery system has emerged as an innovative area of research, this system helps in delivering the drugs 
and macromolecules through skin into systemic circulation. At present, the worldwide market of Transdermal patch has reached 2 
billion pounds. Many drugs like Estrogen, Progestrone, Nitroglycerine, Clonodine etc. are fabricated in form of Transdermal patches 
due to its ability to deliver the drug in non-invasive manner and also to overcome the problems associated with oral route. Although 
the Transdermal patches deliver the drug at predetermined rate1, the partitioning of drug from the system to the skin and then 
penetration through different layers of skin can be altered by adding penetration enhancers that can be physical or chemical in nature. 
This article deals with the role of different chemicals that can be used as penetration enhancer. 
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INTRODUCTION  
Drug delivery trough skin 
Skin being the largest organ of the body, has total area of 
about 20 square feet. it protects us from microbes and other 
ailments , helps to  regulate body temperature, and permits 
the sensations of touch, heat, and cold 
2
. 
Layers of skin 
Non-viable epidermis (stratum corneum)    
It is the outer most layer of skin, being an actual physical 
barrier to most substance that come in contact with the 
skin, it acts as barrier to the entry of foreign substances . 
Stratum corneum is 10 to 20 cell layer thick over most of 
the body.  The composition of Stratum corneum comprises 
of lipids like phospholipids, cholesterol, neutral lipids etc. 
The other component being proteins, the major fraction of 
which is Keratin. 
Viable epidermis    
This layer of the skin is found between the stratum 
corneum and the dermis, the thickness ranges from 50- 100 
µm. The structure of the cells in the viable epidermis is 
physiochemical similar to other living tissues. The water 
content is about 90%.   
Dermis    
Just beneath the viable epidermis is the dermis. It is a 
structural fibrin and very few cells are like it can be found 
histologically in normal tissue. Dermis thickness range 
from 2000 to 3000 µm and consists of a matrix of loose 
connective tissue composed of fibrous protein embedded in 
an amphorphose ground substance.        
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Subcutaneous connective tissue    
The subcutaneous tissue or hypodermis is not actually 
considered a true part of the structured connective tissue is 
composed of loose textured, white, fibrous connective 
tissue containing blood and lymph vessels, secretory pores 
of the sweat gland and cutaneous nerves. Most 
investigators consider drug permeating through the skin 
enter the circulatory system before reaching the 
hypodermis, although the fatty tissue could serve as a depot 
of the drug.      
Sites of drug penetration through skin
3
 
Intercellular route: it is the most common pathway through 
which the drugs cross through the skin, the drugs pass 
through the small gaps between the cells of skin 
Transcellular route: drugs pass the skin through the 
keratinocyte cells 
Follicular route: drugs pass through sweat gland, hair 
follicles and sebaceous glands 
Penetration enhancers:  
Chemical penetration enhancers are proven to increase the 
transport of drug across the skin layers. They show their 
effect by different mechanisms that depend on the chemical 
nature of penetration enhancer, the mechanism may include 
disruption of lipid bilayers of stratum corneum or 
extraction of intercellular protein; Keratin and thus modify 
the penetration ability of drugs
4
or may improve the 
partitioning of drug due to solvent action. Chemical 
penetration enhances temporarily diminish the barrier 
nature of skin and known to accelerate or enhance drug 
flux. 
 
Properties of chemical penetration enhancers
5
 
 
 
Classes of penetration enhancers 
 Fatty acids 
 Fatty alcohols 
 Terpenes 
 Sulfoxides 
 Anionic surfactants 
 Cationic surfactants 
 Non-ionic surfactants 
 Zwitter ion surfactants 
 Ureas 
Fatty acids like oleic acid, linolenic acid, palmitoleic acid 
etc. Are included in GRAS (generally regarded as safe) list 
and are found to be effective penetration enhancers that 
could be incorporated in transdermal patches, the acid 
interact with the lipoidal components of stratum corneum 
and may modify the extent of partitioning of drug from the 
patch and its penetration into skin. The efficacy of an acid 
as enhancer depends upon its structure, length of alkyl 
chain and extent of unsaturation
6
. Fatty acids with short 
chain are found to be more effective in disrupting the 
lipoidal component of stratum corneum when they are 
incorporated in nonpolar solvents; on the contrary long 
chain fatty acids are more effective in polar solvents. In 
case of saturated fatty acid a polar head with C10 to C12 
helps in potentiating the efficacy of enhancer where as in 
case of unsaturated fatty acid a polar head with C18 gives 
optimum effect. 
Fatty alcohol and glycols solvents like ethanol, propylene 
glycol, diethylene glycol, manitol etc. are known to 
increase the penetration of several compounds. The 
mechanism by which these solvents act is based on the 
extraction of lipids from cells of stratum corneum
7
 the 
extraction of lipids result in formation of pores thus 
increasing the cutaneous hydration and solubility of 
solutes. 
Terpenes natural terpenes like Anithole, Camphor, 
Borneol , Eugenol etc. are known to exhibit penetration 
enhancing ability as exhibited by several researches, the 
Compatible with 
formulation 
ingredients 
No damage to 
viable cells of skin 
Short onset of 
action  
Economical and 
ease of availability 
Biodegradable and 
biocompatible 
Reversible change 
in morphology of 
skin 
Non- toxic, Non- 
irritant 
Properties of ideal 
Penetration 
enhancers 
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exact mechanism by which terpenes act is not clear but 
experimentally it has been demonstrated that they act by 
several ways like helping the drug molecule to diffuse 
trough stratum corneum by extractin intercellular lipids, 
they may also extract lipids of stratum corneum and 
breaking of hydrogen bond. They may also act by 
increasing the lipid fluidity and improving the partitioning 
of drug. Camphor sows its action by disrupting  the regular 
organization of stratum corneum 
8,9,10
. 
Sulfoxides: sulfoxides and similar molecules like DMSO 
(dimethyl sulfoxide), DMF (dimethyl formamide) etc. Are 
known to demonstrate penetration enhancing power. 
DMSO is a commonly explored penetration enhancer, it is 
an aprotic solvent that has been used to prepare topical 
formulations for several drugs like antibiotics, steroids, 
narcotics etc
11
. DMSO causes structural changes in stratum 
corneum layer , it interacts with α- keratin proteins and 
convert them to β-sheet conformation, these 
conformational alterations in skin layer as well as DMSO 
induced variations in lipid composition of skin are 
responsible for it penetration enhancing power across the 
skin 
12
. Although both DMSO and DMF have good 
penetration enhancement power but they cause irreversible 
cell membrane damage at higher concentrations above 60% 
13
. 
Anionic surfactants: sodium lauryl sulphate is an example 
of anionic surfactant that has found a wide application as 
penetration enhancer. Anionic surfactants are more 
efficacious than non-ionic or cationic surfactants, it is 
observed that anionic surfactants interact with keratin and 
lipid of stratum corneum cells, it alter the skin permeability 
by uncoiling the keratin filament, by increasing the fluidity 
of epidermal cells and also by increasing the hydration of 
skin due to hydrophobic interaction of alkyl chain with skin 
structure. 
14, 15
 
Cationic surfactants: cationic surfactants show interaction 
with the keratin fibrils of the cornified cells and result in 
disruption of cellular-lipid matrix. The cationic surfactants 
may also show interaction with anionic components of the 
stratum corneum and thus cause a change in electronic 
property at the site, and thus stimulate the passage of the 
anionic drug across the skin layer
16
. 
Non-ionic surfactants:  Non-ionic surfactants demonstrate 
their penetration enhancer ability by causing the 
fluidization of stratum corneum, the surfactant initially 
penetrates into the intercellular spaces of stratum corneum 
due to which fluidity is increased because of solubilisation 
and extraction of lipid. The surfactant may also interact 
with the keratin filaments and result in disruption of cells of 
stratum corneum
17
. 
Zwitterionic surfactants: dodecylbetaine, 
hexadecylbetaine, hexadecylsulfobetaine, N, N–
dimethyl–N-dodecyl amine oxide, 
dodecyltrimethylammonium bromide etc. are few 
zwitterinic surfactants that have experimentally 
demonstrated their ability to act as penetration enhancer; 
they act by solubilization of lipids of stratum corneum
18
. 
Ureas: urea and its derivatives have been used in topical 
and transdermal preparations due to its mosturising, 
keratolytic and penetration enhancing applicatios
19
. Urea 
causes the hydration of stratum corneum by the 
formation of hydrophilic channels within the barrier 
layer of skin. They are also known to cause disruption of 
lipid matrix of stratum corneum thereby increasing the 
penetration of molecules across the skin. A cyclic 
structure in urea derivatives make them biodegradable 
and non toxic which makes them suitable for their role 
as penetration enhasncer
20
. 
Research infield of Transdermal patches 
1. Formulation of patches of Repaglinide to provide 
sustain release and to improve the bioavailability of 
drug
21
. 
2. Formulation and evaluation of transdermal patches 
of Propanalol hydrochloride in order to overcome 
its first pass metabolism and to demonstrate the 
effect of Eugenol as permeation enhancer
22
. 
3. Designing of patches of Diclofenac sodium using 
cellulose acetate phthalate polymer and to study the 
effect of different penetration enhancers like 
isopropylmyristate, Tween 80, oleic acid, linoleic 
acid
23
. 
4. Development of reservoir type transdermal patch of 
iso-sorbide nitrate for sustain effect
24
. 
5. Formulation and evaluation of patch for Donepezil 
with aim to improve its patient compliance and 
therapeutic efficacy
25
. 
6. Formulation of Indomethacin Transdremal patches 
and to evaluate the effect of Patchouli oil as 
penetration enhancer
26
. 
7. Formulation of Trandermal patches of Torasemide 
to avoid first pass metabolism and to avoid irritation 
due to intra-venous therapy of drug
27
. 
8. Preparation of patches of Risperidone to avoid the 
oral side effects of drug in treatment of 
schizophrenia
28
. 
9. Formulation of monolithic Transdermal patches of 
Salbutamol sulphate and to evaluate the effect of 
penetration enhancer
29
. 
10. Formulation of self adhesive matrix type 
Transdermal patch of Ondensetron
30
. 
11. Designing of Transdermal patches for combination 
of Diclofenac and Teriflunomide for treatment of 
rheumatoid arthritis
31
. 
12. Formulaton of matrix type patches of Olanzapine 
and to observe the effect of eucalyptus oil as 
penetration enhancer
32
. 
13. Formulation of Transdermal patch of combination 
of Salbutamol and Ketotifin fumarate
33
. 
14. Formulation of Transdermal patches of Flubiprofen 
and evaluation of milk thistle oil and olive oil as 
penetration enhancer
34
. 
15. Formulation of matrix type Transdermal patch of 
Zaleplon
35
. 
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16. Formulation of Transdermal patch of Papaveirine 
hydrochloride by solvent casting method
36
. 
17. Formulation of Transdermal patch for Aceclofenac 
for rheumatoid arthritis
37
. 
18. Formulation of Transdermal patches of Carvedilol 
with novel polymers like HPMCK100, Eudragit 
RL100, HPMC E5 and PVA
38
. 
19. Reservoir type Transdermal patches of Hydralzine 
hydrochloride and to study the effect of penetration 
enhancers
39
. 
20. Development of Transdermal patch of Lisnopril 
dehydrates to overcome its poor oral 
bioavailability
40
. 
21. Formulation of Transdermal patch of Lamotrigine 
using terpenes as natural penetration enhancer
41
. 
22. Development of Transdermal patch of Nicardipine 
hydrochloride and to evaluate the effect of eugenol 
and DMSO as penetration enhancer
42
. 
23. Designing of Transdermal patch of Atorvastatin43. 
24. Formulation of Transdermal patches of Curcumin 
for wound healing effect
44
. 
25. Formulation if Simvastatin nanoparticles loaded 
transdermal patches
45
. 
26. Formulation and evaluation of matrix type patch of 
Ondensetron
46
. 
27. Formulation of matrix typr patch for Rivastigmine 
tartrate
47
. 
CONCLUSION  
Since Transdermal drug delivery system is emerging as 
a field of interest in order to deliver the drug to the 
patient with compliance, the use of penetration 
enhancers in patches have led to a significant increase in 
drug permeation trough skin however focus should be 
imparted on problems like skin irritation and allergy 
caused by these chemicals when they are used in higher 
concentrations.
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